iPSC‐ and mesenchymoangioblast‐derived mesenchymal stem cells provide greater protection against experimental chronic allergic airways disease compared with a clinically used corticosteroid
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 15, 2019
- Source ID
- 10.1096/fj.201802307r
Entities
People
- Chrishan S. Samuel
- Kilian Kelly
- Rebecca Lim
- Simon G. Royce
- Weiyi Mao
Organizations
- Intelligence Community Postdoctoral Research Fellowship Program
- Monash University
- National Health and Medical Research Council
- University of Melbourne